Last synced on 20 May 2022 at 11:05 pm

SODIUM CHLORIDE INHALATION SOLUTION, 3%, 7%, AND 10%, USP-4ML

Page Type
Cleared 510(K)
PDF
FDA Hosted PDF
* The FDA doesn't provide PDFs for all submissions.
510(k) Number
K120051
510(k) Type
Traditional
Applicant
NEPHRON PHARMACEUTICALS CORP.
Country
United States
FDA Decision
Substantially Equivalent
Decision Date
4/20/2012
Days to Decision
105 days
Submission Type
Summary

SODIUM CHLORIDE INHALATION SOLUTION, 3%, 7%, AND 10%, USP-4ML

Page Type
Cleared 510(K)
PDF
FDA Hosted PDF
* The FDA doesn't provide PDFs for all submissions.
510(k) Number
K120051
510(k) Type
Traditional
Applicant
NEPHRON PHARMACEUTICALS CORP.
Country
United States
FDA Decision
Substantially Equivalent
Decision Date
4/20/2012
Days to Decision
105 days
Submission Type
Summary